Abstract
Research on breast cancer is rapidly progressing, leading to new therapies and treatment approaches, yet in men with the disease it continues to lag. Recently, the FDA released a draft guidance to address this disparity, outlining strategies to improve drug development for men such as including them in clinical trials and using nontraditional data sources.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
